Key terms

About RZLT

Rezolute, Inc. operates as a biopharmaceutical company, which engages in the development of drug therapies for patients with metabolic and orphan diseases. Its products include RZ358-Phase 2, an antibody for the ultra-orphan indication of congenital hyperinsulinism, AB101-Phase 1, a once-weekly injectable basal insulin, and RZ402, which targets diabetic macular edema. The company was founded by Nevan Charles Elam, Ho Young Huh, and Sankaram Mantripragada on July 26, 2010 and is headquartered in Redwood City, CA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest RZLT news

Yesterday 5:32pm ET Rezolute to Present Phase 2 RIZE Study at PES Meeting by TipRanks Yesterday 4:55am ET Rezolute management to meet with BTIG by TipRanks Apr 24 4:55am ET Rezolute management to meet with BTIG by TipRanks Apr 23 8:04am ET Rezolute announces presentation of Phase 2 RIZE study sub-analyses by TipRanks Apr 23 4:55am ET Rezolute management to meet with BTIG by TipRanks Apr 18 12:35am ET Optimistic Buy Rating for Rezolute’s RZ402 Drug Candidate Amid Promising DME Treatment Prospects by TipRanks Apr 17 4:14pm ET Rezolute initiated with a Buy at JonesResearch by TipRanks Apr 17 12:52pm ET Rezolute management to meet with BTIG by TipRanks Mar 11 5:12pm ET Rezolute’s Preclinical Success with New Hypoglycemia Treatment by TipRanks Mar 07 6:30am ET Analysts Offer Insights on Healthcare Companies: PepGen Inc. (PEPG), iTeos Therapeutics (ITOS) and Rezolute (RZLT) by TipRanks Mar 06 7:39am ET Rezolute reports validation of potential use of RZ358 by TipRanks Feb 20 1:55pm ET Rezolute participates in a conference call with Cantor Fitzgerald by TipRanks Feb 20 1:03pm ET Rezolute participates in a conference call with Cantor Fitzgerald by TipRanks Feb 14 12:15am ET Buy Rating Affirmed for Rezolute Amidst Promising Clinical Developments and Stable Financials by TipRanks Feb 13 4:10pm ET Rezolute reports Q2 EPS (27c), consensus (30c) by TipRanks Feb 08 6:19am ET Buy Rating Affirmed for Rezolute’s RZ358 Based on Untapped Market Potential and Therapeutic Efficacy by TipRanks
Nov 24 6:14am ET Stonegate Healthcare Partners Announces Black Friday Biotech Special Report For an "XBI-MAS" by NewsFile Jun 01 8:45am ET Stonegate Healthcare Partners Announces Publishing of a Thematic Report - Beyond VEGF: Therapies Revolutionizing Diabetic Eye Disease by NewsFile

RZLT Financials

1-year income & revenue

Key terms

RZLT Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

RZLT Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Student demonstrators occupy the pro-Palestinian "Gaza Solidarity Encampment" on the West Lawn of Columbia University on April 24, 2024 in New York City.
Michael M. Santiago/Getty Images
What the pro-Palestinian protesters on college campuses actually want
People walk by the New York Stock Exchange (NYSE) on March 20, 2024 in New York City. The Dow was up slightly in late morning trading as traders analyze the Federal Reserve's latest decision on interest rates.
Spencer Platt/Getty Images
Stagflation fears just hit Wall Street. Now for the next crucial report on prices
Meta headquarters pictured on February 02, 2023 in Menlo Park, California.
Justin Sullivan/Getty Images
Meta’s stock plunges 15% on ‘aggressive’ AI spending plans
GettyImages-1159438448 copy.jpg
Lyndon Stratford/iStockphoto/Getty Images
Americans are falling behind on their payments